A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes

Diabetes Technology and Therapeutics

Volumn 19, Issue 3, 2017, Pages 164-172

  Ólafsdóttir, Arndís F ^a,c   Attvall, Stig ^b,c   Sandgren, Ulrika ^b   Dahlqvist, Sofia ^a   Pivodic, Aldina ^d   Skrtic, Stanko ^c,e   Theodorsson, Elvar ^f   Lind, Marcus ^a,c  

^a NU Hospital Organization   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Statistiska Konsultgruppen   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

^f LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Accuracy; Diabetes mellitus; Flash glucose monitor

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; ADULT DISEASE; AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CAPILLARY BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; VISUAL ANALOG SCALE; ADOLESCENT; ANALYSIS; BLOOD; DEVICES; EVALUATION STUDY; MIDDLE AGED; PATIENT SATISFACTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; YOUNG ADULT;

EID: 85015274594     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2016.0392     Document Type: Article

References (21)

1. International Diabetes Federation: IDF Diabetes Atlas, 7th ed. Brussels: International Diabetes Federation (IDF), 2015.
2. Hanås R: Type 1 Diabetes in Children, Adolescents and Young Adults. 6th ed. Uddevalla: BetaMed; 2015.
3. Diabetes Control and Complications Trial Study Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
4. Ahlén E, Pivodic A, Wedel H, et al.: Glycemic control, renal complications, and current smoking in relation to excess risk of mortality in persons with type 1 diabetes. J Diabetes Sci Technol 2016;10:1006-1014.
5. Lind M, Svensson AM, Kosiborod M, et al.: Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014;371:1972-1982.
6. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S33-S50.
7. Attvall S. Egenmätning av blodglukos vid diabetes- regional Medicinsk Riktlinje-Läkemedel. 2016; https://alfresco .vgregion.se/alfresco/service/vgr/storage/node/content/3603/ Egenm%C3%A4tning%20av%20blodglukos%20vid%20 diabetes.pdf?a=false&guest=true (accessed February 9, 2017).
8. Lind M, Polonsky W, Hirsch IB, et al.: Continuous glucose monitoring vs conventional therapy for Glycemic Control in adults with type 1 diabetes treated with multiple daily insulin Injections: The GOLD Randomized Clinical Trial. JAMA 2017;317:379-387.
9. Battelino T, Conget I, Olsen B, et al.: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012;55:3155-3162.
10. Beck RW, Riddlesworth T, Ruedy K, et al.: Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND Randomized Clinical Trial. JAMA 2017;317:371-378.
11. Produkter CL: Sortimentskatalog 2015 diabeteshjälpmedel. 2015; http://www.vgregion.se/upload/Regionservice/CLP/ Diabetes/Sortimentskatalog%20Diabetes%202017.pdf (accessed February 9, 2017).
12. Hannestad U, Lundblad A: Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood. Clin Chem 1997;43:794-800.
13. Kos S, van Meerkerk A, van der Linden J, et al.: Validation of a new generation POCT glucose device with emphasis on aspects important for glycemic control in the hospital care. Clin Chem Lab Med 2012;50:1573-1580.
14. Andelin M, Kropff J, Matuleviciene V, et al.: Assessing the accuracy of continuous glucose monitoring (CGM) calibrated with capillary values using capillary or venous glucose levels as a reference. J Diabetes Sci Technol 2016; 10:876-884.
15. Matuleviciene V, Joseph JI, Andelin M, et al.: A clinical trial of the accuracy and treatment experience of the Dex-com G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther 2014;16:759-767.
16. Bailey T, Bode BW, Christiansen MP, et al.: The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther 2015;17: 787-794.
17. Armbruster D: Measurement traceability and US IVD manufacturers: the impact of metrology. Accredit Qual Assur 2009;14:393-398.
18. Bièvre PD, Kaarls R, Peiser HS, et al.: Measurement principles for traceability in chemical analysis. Accredit Quality Assurance 1996;1:3.
19. Bièvre PD, Kaarls R, Peiser HS, et al.: Protocols for traceability in chemical analysis. Accredit Qual Assur 1997;2:270.
20. Bièvre P, Kaarls R, Peiser HS, et al.: Protocols for traceability in chemical analysis. Accredit Qual Assur 1997;2:168.
21. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al.: Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388:2254-2263.